Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC) Meeting Abstract

  


Authors: Vargas Pivato de Almeida, D.; Anderson, J.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Dayan, E. S.; Curley, T.; Arauz, G.; Baser, R. E.; Scher, H. I.; Autio, K. A.
Abstract Title: Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC)
Meeting Title: 56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 38
Issue: 15 Suppl.
Meeting Dates: 2020 May 29-31
Meeting Location: Virtual
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2020-05-20
Language: English
ACCESSION: WOS:000560368308551
PROVIDER: wos
DOI: 10.1200/JCO.2020.38.15_suppl.e24174
Notes: Meeting Abstract: e24174 -- Source: Wos
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Raymond E Baser
    133 Baser
  2. Susan Slovin
    254 Slovin
  3. Michael Morris
    577 Morris
  4. Karen Anne Autio
    119 Autio
  5. Tracy B Smart-Curley
    70 Smart-Curley
  6. Gabrielle Arauz
    14 Arauz
  7. Howard Scher
    1130 Scher
  8. Daniel C Danila
    154 Danila
  9. Wassim Abida
    154 Abida
  10. Erica Simone Dayan
    13 Dayan
  11. Justine M Anderson
    3 Anderson
  12. Daniel Vargas Pivato De Almeida
    5 Vargas Pivato De Almeida
Related MSK Work